Company intelligence / Profile preview

Tzu Cancer Therapeutics

Amsterdam, North Holland, Netherlandstzu.nl ↗

Ownership: Private
Development stage: Other

Overview

Tzu Cancer Therapeutics is developing technology to isolate and characterize circulating tumor cells from blood samples, aiming to use this information for the creation of personalized cancer therapies. The company is in early stages and has not reported clinical results yet.

Therapeutic areas: Oncology
Modalities: Personalized therapy (based on molecular analysis of circulating tumor cells)Small molecule (inferred, as CTC analysis often leads to targeted therapies)
Industry: Biotech

Beyond the preview

Go deeper on Tzu Cancer Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tzu Cancer Therapeutics.

Explore the full profile